TONIX PHARMACEUTICALS HOLDING CORP. Increase (Decrease) in Accounts Payable, Trade
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Increase (Decrease) in Accounts Payable, Trade of $937.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-08-10
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was -$596.00K, a 119.45% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $1.53M.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was -$738.00K, a 227.02% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was $1.02M.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in accounts payable, trade for fiscal 2025 was $2.99M, a 222.98% increase from fiscal 2024.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in accounts payable, trade for fiscal 2024 was $927.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in accounts payable, trade for fiscal 2023 was -$3.49M.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in accounts payable, trade for fiscal 2022 was -$1.04M, a 129.64% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 3 month as first filed | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 6 month as first filed | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 9 month as first filed | Increase (Decrease) in Accounts Payable, Trade 12 month | Increase (Decrease) in Accounts Payable, Trade 12 month as first filed | Increase (Decrease) in Accounts Payable, Trade 55 month | Increase (Decrease) in Accounts Payable, Trade 58 month | Increase (Decrease) in Accounts Payable, Trade 61 month | Increase (Decrease) in Accounts Payable, Trade 64 month | Increase (Decrease) in Accounts Payable, Trade 67 month | Increase (Decrease) in Accounts Payable, Trade 70 month | Increase (Decrease) in Accounts Payable, Trade 73 month | Increase (Decrease) in Accounts Payable, Trade 76 month | Increase (Decrease) in Accounts Payable, Trade 79 month | Increase (Decrease) in Accounts Payable, Trade 82 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$596.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $937.00K 10-Q · filed 2026-08-10 | $199.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.22M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2026-03-31 | $1.53M 10-Q · filed 2026-05-11 | $795.00K derived: sum of 2 quarters · filed 2026-05-11 | $1.82M derived: sum of 3 quarters · filed 2026-05-11 | $4.88M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2025-12-31 | -$738.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $283.00K derived: sum of 2 quarters · filed 2026-03-12 | $3.35M derived: sum of 3 quarters · filed 2026-08-10 | $2.99M 10-K · filed 2026-03-12 | ||||||||||||||
| 2025-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $4.08M derived: sum of 2 quarters · filed 2026-08-10 | $3.73M 10-Q · filed 2025-11-10 | $4.31M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2025-06-30 | $3.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $2.71M 10-Q · filed 2026-08-10 | $3.29M derived: sum of 3 quarters · filed 2026-08-10 | -$3.06M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2025-03-31 | -$353.00K 10-Q · filed 2026-05-11 | $228.00K derived: sum of 2 quarters · filed 2026-05-11 | -$6.13M derived: sum of 3 quarters · filed 2026-05-11 | -$2.40M derived: sum of 4 quarters · filed 2026-05-11 | ||||||||||||||
| 2024-12-31 | $581.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$5.78M derived: sum of 2 quarters · filed 2026-03-12 | -$2.05M derived: sum of 3 quarters · filed 2026-03-12 | $927.00K 10-K · filed 2026-03-12 | ||||||||||||||
| 2024-09-30 | -$6.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.63M derived: sum of 2 quarters · filed 2025-11-10 | $346.00K 10-Q · filed 2025-11-10 | -$3.59M derived: sum of 4 quarters · filed 2025-11-10 | ||||||||||||||
| 2024-06-30 | $3.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $6.70M 10-Q · filed 2025-08-11 | $2.77M derived: sum of 3 quarters · filed 2025-08-11 | $3.78M derived: sum of 4 quarters · filed 2025-08-11 | ||||||||||||||
| 2024-03-31 | $2.98M 10-Q · filed 2025-05-12 | -$960.00K derived: sum of 2 quarters · filed 2025-05-12 | $57.00K derived: sum of 3 quarters · filed 2025-05-12 | -$1.09M derived: sum of 4 quarters · filed 2025-05-12 | ||||||||||||||
| 2023-12-31 | -$3.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$2.92M derived: sum of 2 quarters · filed 2025-03-18 | -$4.07M derived: sum of 3 quarters · filed 2025-03-18 | -$3.49M 10-K · filed 2025-03-18 | ||||||||||||||
| 2023-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$129.00K derived: sum of 2 quarters · filed 2024-11-12 | $446.00K 10-Q · filed 2024-11-12 | $3.48M derived: sum of 4 quarters · filed 2024-11-12 | ||||||||||||||
| 2023-06-30 | -$1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-16 | -$571.00K 10-Q · filed 2024-08-16 | $2.46M derived: sum of 3 quarters · filed 2024-08-16 | -$52.00K derived: sum of 4 quarters · filed 2024-08-16 | ||||||||||||||
| 2023-03-31 | $575.00K 10-Q · filed 2024-05-13 | $3.61M derived: sum of 2 quarters · filed 2024-05-13 | $1.09M derived: sum of 3 quarters · filed 2024-05-13 | $2.64M derived: sum of 4 quarters · filed 2024-05-13 | ||||||||||||||
| 2022-12-31 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $519.00K derived: sum of 2 quarters · filed 2024-04-01 | $2.07M derived: sum of 3 quarters · filed 2024-04-01 | -$1.04M 10-K · filed 2024-04-01 | ||||||||||||||
| 2022-09-30 | -$2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$966.00K derived: sum of 2 quarters · filed 2023-11-09 | -$4.08M 10-Q · filed 2023-11-09 | -$3.92M derived: sum of 4 quarters · filed 2023-11-09 | ||||||||||||||
| 2022-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.56M 10-Q · filed 2023-08-10 | -$1.41M derived: sum of 3 quarters · filed 2023-08-10 | $3.15M derived: sum of 4 quarters · filed 2023-08-10 | ||||||||||||||
| 2022-03-31 | -$3.11M 10-Q · filed 2023-05-08 | -$2.96M derived: sum of 2 quarters · filed 2023-05-08 | $1.60M derived: sum of 3 quarters · filed 2023-05-08 | $2.15M derived: sum of 4 quarters · filed 2023-05-08 | ||||||||||||||
| 2021-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $4.72M derived: sum of 2 quarters · filed 2023-03-13 | $5.26M derived: sum of 3 quarters · filed 2023-03-13 | $3.53M 10-K · filed 2023-03-13 | ||||||||||||||
| 2021-09-30 | $4.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $5.11M derived: sum of 2 quarters · filed 2022-11-07 | $3.37M 10-Q · filed 2022-11-07 | $6.20M derived: sum of 4 quarters · filed 2022-11-07 | ||||||||||||||
| 2021-06-30 | $548.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$1.19M 10-Q · filed 2022-08-08 | $1.64M derived: sum of 3 quarters · filed 2022-08-08 | $219.00K derived: sum of 4 quarters · filed 2022-08-08 | ||||||||||||||
| 2021-03-31 | -$1.74M 10-Q · filed 2022-05-09 | $1.09M derived: sum of 2 quarters · filed 2022-05-09 | -$329.00K derived: sum of 3 quarters · filed 2022-05-09 | $1.45M derived: sum of 4 quarters · filed 2022-05-09 | ||||||||||||||
| 2020-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $1.41M derived: sum of 2 quarters · filed 2022-03-14 | $3.19M derived: sum of 3 quarters · filed 2022-03-14 | $1.53M 10-K · filed 2022-03-14 | ||||||||||||||
| 2020-09-30 | -$1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $361.00K derived: sum of 2 quarters · filed 2021-11-08 | -$1.30M 10-Q · filed 2021-11-08 | $647.00K derived: sum of 4 quarters · filed 2021-11-08 | ||||||||||||||
| 2020-06-30 | $1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $118.00K 10-Q · filed 2021-08-09 | $2.07M derived: sum of 3 quarters · filed 2021-08-09 | $2.14M derived: sum of 4 quarters · filed 2021-08-09 | ||||||||||||||
| 2020-03-31 | -$1.66M 10-Q · filed 2021-05-10 | $286.00K derived: sum of 2 quarters · filed 2021-05-10 | $359.00K derived: sum of 3 quarters · filed 2021-05-10 | $271.00K derived: sum of 4 quarters · filed 2021-05-10 | ||||||||||||||
| 2019-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $2.02M derived: sum of 2 quarters · filed 2021-03-15 | $1.93M derived: sum of 3 quarters · filed 2021-03-15 | $1.66M 10-K · filed 2021-03-15 | ||||||||||||||
| 2019-09-30 | $73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$15.00K derived: sum of 2 quarters · filed 2020-11-09 | -$285.00K 10-Q · filed 2020-11-09 | $70.00K derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||||||
| 2019-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$358.00K 10-Q · filed 2020-08-10 | -$3.00K derived: sum of 3 quarters · filed 2020-08-10 | -$594.00K derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||||
| 2019-03-31 | -$270.00K 10-Q · filed 2020-05-12 | $85.00K derived: sum of 2 quarters · filed 2020-05-12 | -$506.00K derived: sum of 3 quarters · filed 2020-05-12 | -$132.00K derived: sum of 4 quarters · filed 2020-05-12 | ||||||||||||||
| 2018-12-31 | $355.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | -$236.00K derived: sum of 2 quarters · filed 2020-03-24 | $138.00K derived: sum of 3 quarters · filed 2020-03-24 | $106.00K 10-K · filed 2020-03-24 | ||||||||||||||
| 2018-09-30 | -$591.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$217.00K derived: sum of 2 quarters · filed 2019-11-08 | -$249.00K 10-Q · filed 2019-11-08 | $665.00K derived: sum of 4 quarters · filed 2019-11-08 | ||||||||||||||
| 2018-06-30 | $374.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $342.00K 10-Q · filed 2019-08-12 | $1.26M derived: sum of 3 quarters · filed 2019-08-12 | $459.00K derived: sum of 4 quarters · filed 2019-08-12 | ||||||||||||||
| 2018-03-31 | -$32.00K 10-Q · filed 2019-05-13 | $882.00K derived: sum of 2 quarters · filed 2019-05-13 | $85.00K derived: sum of 3 quarters · filed 2019-05-13 | $423.00K derived: sum of 4 quarters · filed 2019-05-13 | ||||||||||||||
| 2017-12-31 | $914.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $117.00K derived: sum of 2 quarters · filed 2019-03-18 | $455.00K derived: sum of 3 quarters · filed 2019-03-18 | $424.00K 10-K · filed 2019-03-18 | ||||||||||||||
| 2017-09-30 | -$797.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$459.00K derived: sum of 2 quarters · filed 2018-11-09 | -$490.00K 10-Q · filed 2018-11-09 | $490.00K 10-Q · filed 2017-11-06 | -$561.00K derived: sum of 4 quarters · filed 2018-11-09 | |||||||||||||
| 2017-06-30 | $338.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $307.00K 10-Q · filed 2018-08-13 | $236.00K derived: sum of 3 quarters · filed 2018-08-13 | -$761.00K derived: sum of 4 quarters · filed 2018-08-13 | ||||||||||||||
| 2017-03-31 | -$31.00K 10-Q · filed 2018-05-11 | -$102.00K derived: sum of 2 quarters · filed 2018-05-11 | -$1.10M derived: sum of 3 quarters · filed 2018-05-11 | -$1.23M derived: sum of 4 quarters · filed 2018-05-11 | ||||||||||||||
| 2016-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$1.07M derived: sum of 2 quarters · filed 2018-03-09 | -$1.20M derived: sum of 3 quarters · filed 2018-03-09 | -$2.19M 10-K · filed 2018-03-09 | ||||||||||||||
| 2016-09-30 | -$997.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$1.13M derived: sum of 2 quarters · filed 2017-11-06 | -$2.11M 10-Q · filed 2017-11-06 | -$1.48M derived: sum of 4 quarters · filed 2017-11-06 | ||||||||||||||
| 2016-06-30 | -$131.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$1.12M 10-Q · filed 2017-08-11 | -$482.00K derived: sum of 3 quarters · filed 2017-08-11 | -$819.00K derived: sum of 4 quarters · filed 2017-08-11 | ||||||||||||||
| 2016-03-31 | -$986.00K 10-Q · filed 2017-05-12 | -$351.00K derived: sum of 2 quarters · filed 2017-05-12 | -$688.00K derived: sum of 3 quarters · filed 2017-05-12 | $95.00K derived: sum of 4 quarters · filed 2017-05-12 | ||||||||||||||
| 2015-12-31 | $635.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | $298.00K derived: sum of 2 quarters · filed 2017-04-13 | $1.08M derived: sum of 3 quarters · filed 2017-04-13 | $1.58M 10-K · filed 2017-04-13 | ||||||||||||||
| 2015-09-30 | -$337.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $446.00K derived: sum of 2 quarters · filed 2016-11-10 | $948.00K 10-Q · filed 2016-11-10 | -$12.00K derived: sum of 4 quarters · filed 2016-11-10 | ||||||||||||||
| 2015-06-30 | $783.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $1.28M 10-Q · filed 2016-08-05 | $325.00K derived: sum of 3 quarters · filed 2016-08-05 | $1.26M derived: sum of 4 quarters · filed 2016-08-05 | ||||||||||||||
| 2015-03-31 | $502.00K 10-Q · filed 2016-05-06 | -$458.00K derived: sum of 2 quarters · filed 2016-05-06 | $476.00K derived: sum of 3 quarters · filed 2016-05-06 | $595.00K derived: sum of 4 quarters · filed 2016-05-06 | ||||||||||||||
| 2014-12-31 | -$960.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | -$26.00K derived: sum of 2 quarters · filed 2016-03-03 | $93.00K derived: sum of 3 quarters · filed 2016-03-03 | $728.00K 10-K · filed 2016-03-03 | ||||||||||||||
| 2014-09-30 | $934.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.05M derived: sum of 2 quarters · filed 2015-11-06 | $1.69M 10-Q · filed 2015-11-06 | $1.47M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||||||
| 2014-06-30 | $119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $754.00K 10-Q · filed 2015-08-07 | $534.00K derived: sum of 3 quarters · filed 2016-03-03 | $58.00K derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||||||
| 2014-03-31 | $635.00K 10-Q · filed 2015-05-08 | $415.00K derived: sum of 2 quarters · filed 2016-03-03 | -$61.00K derived: sum of 3 quarters · filed 2016-03-03 | $531.00K derived: sum of 4 quarters · filed 2016-03-03 | $1.40M 10-Q · filed 2014-05-13 | |||||||||||||
| 2013-12-31 | -$220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | -$696.00K derived: sum of 2 quarters · filed 2016-03-03 | -$104.00K derived: sum of 3 quarters · filed 2016-03-03 | -$60.00K 10-K · filed 2016-03-03 | $766.00K 10-K · filed 2014-03-28 | |||||||||||||
| 2013-09-30 | -$476.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $116.00K derived: sum of 2 quarters · filed 2014-11-07 | $160.00K 10-Q · filed 2014-11-07 | $159.97K 10-Q · filed 2013-11-13 | $289.81K derived: sum of 4 quarters · filed 2014-11-07 | $985.81K 10-Q · filed 2013-11-13 | ||||||||||||
| 2013-06-30 | $592.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $636.00K 10-Q · filed 2014-08-08 | $635.40K 10-Q · filed 2013-08-14 | $765.82K derived: sum of 3 quarters · filed 2014-08-08 | $976.26K derived: sum of 4 quarters · filed 2014-08-08 | $1.46M 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $44.00K 10-Q · filed 2014-05-13 | $44.26K 10-Q · filed 2013-05-07 | $173.81K derived: sum of 2 quarters · filed 2014-05-13 | $384.26K derived: sum of 3 quarters · filed 2014-05-13 | $688.79K derived: sum of 4 quarters · filed 2014-05-13 | $870.10K 10-Q · filed 2013-05-07 | ||||||||||||
| 2012-12-31 | $129.81K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $340.26K derived: sum of 2 quarters · filed 2014-03-28 | $644.79K derived: sum of 3 quarters · filed 2014-03-28 | $132.00K 10-K · filed 2014-03-28 | $130.64K 10-K · filed 2013-03-11 | $825.84K 10-K/A · filed 2013-11-22 | ||||||||||||
| 2012-09-30 | $210.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $514.98K derived: sum of 2 quarters · filed 2013-11-13 | $2.19K 10-Q · filed 2013-11-13 | -$159.93K derived: sum of 4 quarters · filed 2013-11-22 | $697.38K 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | $304.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$208.26K 10-Q · filed 2013-08-14 | -$370.38K derived: sum of 3 quarters · filed 2013-11-22 | $17.57K derived: sum of 4 quarters · filed 2013-11-22 | $486.94K 10-Q · filed 2012-08-13 | |||||||||||||
| 2012-03-31 | -$512.79K 10-Q · filed 2013-05-07 | -$674.91K derived: sum of 2 quarters · filed 2013-11-22 | -$286.96K derived: sum of 3 quarters · filed 2013-11-22 | -$212.71K derived: sum of 4 quarters · filed 2013-11-22 | $182.41K 10-Q · filed 2012-05-15 | |||||||||||||
| 2011-12-31 | -$162.12K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-22 | $225.83K derived: sum of 2 quarters · filed 2013-11-22 | $300.08K derived: sum of 3 quarters · filed 2013-11-22 | $377.45K 10-K/A · filed 2013-11-22 | $695.20K 10-K · filed 2012-03-30 | |||||||||||||
| 2011-09-30 | $387.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $462.20K derived: sum of 2 quarters · filed 2012-11-14 | $539.57K 10-Q · filed 2012-11-14 | |||||||||||||||
| 2011-06-30 | $74.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $151.62K 10-Q · filed 2012-08-13 | ||||||||||||||||
| 2011-03-31 | $77.37K 10-Q · filed 2012-05-15 | |||||||||||||||||
| 2010-12-31 | $294.13K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |